Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology

被引:6
作者
Alidousty, Christina [1 ]
Baar, Till [2 ]
Heydt, Carina [1 ]
Wagener-Ryczek, Svenja [1 ]
Kron, Anna [3 ,4 ,5 ]
Wolf, Juergen [3 ,4 ,5 ]
Buettner, Reinhard [1 ,3 ,4 ]
Schultheis, Anne Maria [1 ]
机构
[1] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[2] Univ Cologne, Fac Med, Inst Med Stat & Computat Biol, Cologne, Germany
[3] Network Genom Med, Cologne, Germany
[4] Univ Hosp Cologne, Dept Internal Med 1, Lung Canc Grp Cologne, Cologne, Germany
[5] Ctr Integrated Oncol Cologne Bonn, Cologne, Germany
关键词
Non-small cell lung cancer (NSCLC); anaplastic lymphoma kinase (ALK); ALK plus -adenocarcinoma; TP53; biomarker; ANAPLASTIC LYMPHOMA KINASE; CRIZOTINIB RESISTANCE; PRACTICE GUIDELINES; TARGETED THERAPY; GROWTH-FACTOR; ALK; MUTATIONS; RECEPTOR; IDENTIFICATION; DIAGNOSIS;
D O I
10.21037/jtd.2018.12.03
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
One distinct molecular subtype of non-small cell lung cancer (NSCLC) is defined by rearrangement of the anaplastic lymphoma kinase (ALK). The increasing knowledge over the last years has enabled the continuous improvement of ALK inhibitors; however, resistance in these patients remains a major concern. In this review, we summarize recent findings in ALK+-adenocarcinoma of the lung, highlighting the role of TP53 mutations in this specific cancer type and suggest new diagnostic strategies for the future, in order to improve patient's outcome.
引用
收藏
页码:S3 / S8
页数:6
相关论文
共 50 条
[41]   Molecular pathology of lung cancer: current standards and further developments [J].
Falk, Markus ;
Schatz, Stefanie ;
Heukamp, Lukas C. .
PNEUMOLOGE, 2019, 16 (06) :333-342
[42]   Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications [J].
Zito Marino, Federica ;
Bianco, Roberto ;
Accardol, Marina ;
Ronchi, Andrea ;
Cozzolino, Immacolata ;
Morgillo, Floriana ;
Rossi, Giulio ;
Franco, Renato .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (07) :981-989
[43]   Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance [J].
Alqualo, Nathalia Oliveira ;
Campos-Fernandez, Esther ;
Picolo, Bianca Uliana ;
Ferreira, Emanuelle Lorrayne ;
Henriques, Laila Machado ;
Lorenti, Sabrina ;
Moreira, Danilo Caixeta ;
Simiao, Maria Paula Silva ;
Oliveira, Luciana Beatriz Tiago ;
Alonso-Goulart, Vivian .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 194
[44]   Clinical Advances in Molecular Biomarkers for Cancer Diagnosis and Therapy [J].
Sethi, Seema ;
Ali, Shadan ;
Philip, Philip A. ;
Sarkar, Fazlul H. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (07) :14771-14784
[45]   Incorporating molecular biomarkers into clinical practice for gastric cancer [J].
Nakamura, Shunsuke ;
Kanda, Mitsuro ;
Kodera, Yasuhiro .
EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (09) :757-771
[46]   Molecular biology of colorectal cancer and clinical consequences for colorectal cancer syndromes [J].
M. Hahn ;
O. N. Koufaki ;
H. K. Schackert .
Langenbeck's Archives of Surgery, 1998, 383 :389-396
[47]   Molecular biology of colorectal cancer and clinical consequences for colorectal cancer syndromes [J].
Hahn, M ;
Koufaki, ON ;
Schackert, HK .
LANGENBECKS ARCHIVES OF SURGERY, 1998, 383 (06) :389-396
[48]   Role of exosomal microRNAs in lung cancer biology and clinical applications [J].
Hu, Chengping ;
Meiners, Silke ;
Lukas, Christina ;
Stathopoulos, Georgios T. ;
Chen, Jie .
CELL PROLIFERATION, 2020, 53 (06)
[49]   Lung cancer stem cells: Tumor biology and clinical implications [J].
Nurwidya, Fariz ;
Murakami, Akiko ;
Takahashi, Fumiyuki ;
Takahashi, Kazuhisa .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (03) :217-222
[50]   Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance [J].
Lee, Nicholas ;
Canagasingham, Ashan ;
Bajaj, Mohit ;
Shanmugasundaram, Ramesh ;
Hutton, Anthony ;
Bucci, Joseph ;
Graham, Peter ;
Thompson, James ;
Ni, Jie .
FRONTIERS IN ONCOLOGY, 2022, 12